Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.

Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.

Item
http://www.wikidata.org/entity/Q36961037
Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model.HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer.Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model.Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study.Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL.Immunological basis in the pathogenesis and treatment of bladder cancerBacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder.Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.Immune therapies in non-muscle invasive bladder cancer.Replication-competent adenovirus expressing TRAIL synergistically potentiates the antitumor effect of gemcitabine in bladder cancer cells.
P2860

Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.

Item
http://www.wikidata.org/entity/Q36961037
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.
@en
type
label
Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.
@en
prefLabel
Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698